Stefan Rydén
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Global Cancer Incidence and Screening
- Colorectal Cancer Screening and Detection
- Cancer Risks and Factors
Papers in
- Oncology 11
- HER2/EGFR in Cancer Research 4
- Global Cancer Incidence and Screening 4
- Colorectal Cancer Screening and Detection 3
-
- Breast Cancer Treatment Studies 5
- Co-authors
- D. Killander (2 shared papers)Åke Borg (2 shared papers)Håkan Olsson (1 shared paper)Helgi Sigurðsson (1 shared paper)Mårten Fernö (3 shared papers)Larsolof Hafström (5 shared papers)Henrik Møller (5 shared papers)Lennart Bergqvist (4 shared papers)
- Journals
- Acta Oncologica (3 papers)Journal of Surgical Oncology (2 papers)Journal of Hepatology (1 paper)European Journal of Cancer (1 paper)The Breast (1 paper)
- Partner nations
- SwedenUnited StatesJapan
In The Last Decade
Stefan Rydén
18 papers receiving 567 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 210
- Oncology 366
- Hepatology 48
- Radiology, Nuclear Medicine and Imaging 116
- Genetics 140
Countries citing papers authored by Stefan Rydén
This map shows the geographic impact of Stefan Rydén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Rydén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Rydén more than expected).
Fields of papers citing papers by Stefan Rydén
This network shows the impact of papers produced by Stefan Rydén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Rydén. The network helps show where Stefan Rydén may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefan Rydén, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 203 | |
| 2 | 1995 | 97 | |
| 3 | 2000 | 66 | |
| 4 | 1982 | 43 | |
| 5 | 1992 | 37 | |
| 6 | The "critical colloid dose" in studies of reticuloendothelial function. | 1987 | 30 |
| 7 | 2007 | 19 | |
| 8 | 2019 | 19 | |
| 9 | 2009 | 15 | |
| 10 | 1988 | 13 | |
| 11 | 1986 | 12 | |
| 12 | 2016 | 7 | |
| 13 | 1984 | 7 | |
| 14 | 1987 | 5 | |
| 15 | 1983 | 5 | |
| 16 | 2020 | 3 | |
| 17 | 1985 | 3 | |
| 18 | 2021 | 2 |
About Stefan Rydén
Stefan Rydén is a scholar working on Oncology, Cancer Research, Economics and Econometrics, Surgery and Radiology, Nuclear Medicine and Imaging, having authored 18 papers that have together received 586 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (5 papers), HER2/EGFR in Cancer Research (4 papers), Global Cancer Incidence and Screening (4 papers), Colorectal Cancer Screening and Detection (3 papers), Estrogen and related hormone effects (3 papers), Economic and Financial Impacts of Cancer (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Statistical Methods in Clinical Trials (2 papers). The work is most often cited by research in Cancer Research (210 citations), Oncology (366 citations), Hepatology (48 citations), Radiology, Nuclear Medicine and Imaging (116 citations) and Genetics (140 citations). Stefan Rydén has collaborated with scholars based in Sweden, United States and Japan. Frequent co-authors include D. Killander, Åke Borg, Håkan Olsson, Helgi Sigurðsson, Mårten Fernö, Larsolof Hafström, Henrik Møller, Lennart Bergqvist, Sven‐Erik Strand and Lennarth Nyström. Their work appears in journals such as Acta Oncologica, Journal of Surgical Oncology, Journal of Hepatology, European Journal of Cancer and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.